Abstract
One of the most valuable tools that have been developed for the study of apoptosis is the availability of recombinant active caspases. The determination of caspase substrate preference, the design of sensitive substrates and potent inhibitors, the resolution of caspase structures, the elucidation of their activation mechanisms, and the identification of their substrates were made possible by the availability of sufficient amounts of enzymatically pure caspases. The current chapter describes at length the expression, purification, and basic enzymatic characterization of apoptotic caspases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cerretti DP et al (1992) Molecular cloning of the interleukin-1β converting enzyme. Science 256:97–100
Thornberry NA et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1beta processing in monocytes. Nature 356:768–774
Yi CH, Yuan J (2009) The Jekyll and Hyde functions of caspases. Dev Cell 16:21–34
Thornberry NA et al (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907–17911
Stennicke HR, Renatus M, Meldal M, Salvesen GS (2000) Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 350:563–568
Lavrik IN, Golks A, Krammer PH (2005) Caspases: pharmacological manipulation of cell death. J Clin Invest 115:2665–2672
Garcia-Calvo M et al (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273:32608–32613
Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384:201–232
Agard NJ, Wells JA (2009) Methods for the proteomic identification of protease substrates. Curr Opin Chem Biol 13:503–509
Demon D et al (2009) Caspase substrates: easily caught in deep waters? Trends Biotechnol 27:680–688
Luthi AU, Martin SJ (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ 14:641–650
Igarashi Y et al (2007) CutDB: a proteolytic event database. Nucleic Acids Res 35:D546–D549
Timmer JC et al (2009) Structural and kinetic determinants of protease substrates. Nat Struct Mol Biol 16:1101–1108
Muppidi JR et al (2006) Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death Differ 13:1641–1650
Bouchier-Hayes L et al (2009) Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol cell 35:830–840
Vegran F, Boidot R, Solary E, Lizard-Nacol S (2011) A short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly. PLoS One 6:e29058
Kamada S, Kikkawa U, Tsujimoto Y, Hunter T (2005) Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem 280:857–860
Beaudouin J, Liesche C, Aschenbrenner S, Horner M, Eils R (2013) Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis. Cell Death Differ 20:599–610
Arakawa T et al (2007) Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys Chem 127:1–8
Baynes BM, Wang DI, Trout BL (2005) Role of arginine in the stabilization of proteins against aggregation. Biochemistry 44:4919–4925
Arakawa T, Tsumoto K (2003) The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 304:148–152
Reddy KR, Lilie H, Rudolph R, Lange C (2005) L-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci 14:929–935
McStay GP, Salvesen GS, Green DR (2008) Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ 15:322–331
Schecter I, Berger M (1967) On the size of the active site in proteases. Biochem Biophys Res Commun 27:157–162
Talanian RV et al (1997) Substrate specificities of caspase family proteases. J Biol Chem 272:9677–9682
Mace PD, Riedl SJ (2010) Molecular cell death platforms and assemblies. Curr Opin Cell Biol 22:828–836
Renatus M, Stennicke HR, Scott FL, Liddington RC, Salvesen GS (2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci U S A 98:14250–14255
Baliga BC, Read SH, Kumar S (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ 11:1234–1241
Wachmann K et al (2010) Activation and specificity of human caspase-10. Biochemistry 49:8307–8315
Boatright KM et al (2003) A unified model for apical caspase activation. Mol Cell 11:529–541
Pop C, Timmer J, Sperandio S, Salvesen GS (2006) The apoptosome activates caspase-9 by dimerization. Mol Cell 22:269–275
Boucher D, Blais V, Denault JB (2012) Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci U S A 109:5669–5674
Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357–9360
Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1416
Denault JB et al (2006) Engineered hybrid dimers: tracking the activation pathway of caspase-7. Mol Cell 23:523–533
Pop C et al (2011) FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 433:447–457
Stennicke HR et al (1999) Caspase-9 can be activated without proteolytic processing. J Biol Chem 274:8359–8362
Boucher D, Blais V, Drag M, Denault JB (2011) Molecular determinants involved in activation of caspase 7. Biosci Rep 31:283–294
Araya R, Takahashi R, Nomura Y (2002) Yeast two-hybrid screening using constitutive-active caspase-7 as bait in the identification of PA28gamma as an effector caspase substrate. Cell Death Differ 9:322–328
Stennicke HR, Salvesen GS (1999) Catalytic properties of the caspases. Cell Death Differ 6:1054–1059
Pop C, Fitzgerald P, Green DR, Salvesen GS (2007) Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 46:4398–4407
Zhou Q, Salvesen GS (1997) Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem J 324:361–364
Stennicke HR et al (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084–27090
Chao Y et al (2005) Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation. PLoS Biol 3:e183
Walters J et al (2009) A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J 424:335–345
Swan ID (1972) The inhibition of hen egg-white lysozyme by imidazole and indole derivatives. J Mol Biol 65:59–62
Bury A (1981) Analysis of protein and peptide mixtures: evaluation of three sodium dodecyl sulphate-polyacrylamide gel electrophoresis buffer systems. J Chromatogr 213:491–500
Edelhoch H (1967) Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6:1948–1954
Zhou Q, Salvesen GS (2000) Viral caspase inhibitors CrmA and p35. Methods Enzymol 322:143–154
Zhou Q et al (1998) Interaction of the baculovirus anti-apoptotic protein p35 with caspases: specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 37:10757–10765
Oberst A et al (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363–367
Oberst A et al (2010) Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem 285:16632–16642
van Raam BJ, Ehrnhoefer DE, Hayden MR, Salvesen GS (2013) Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6. Cell Death Differ 20:86–96
Gray DC, Mahrus S, Wells JA (2010) Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell 142:637–646
Witkowski WA, Hardy JA (2009) L2′ loop is critical for caspase-7 active site formation. Protein Sci 18:1459–1468
Witkowski WA, Hardy JA (2011) A designed redox-controlled caspase. Proc Natl Acad Sci U S A 20(8):1421–1431
Hardy JA, Lam J, Nguyen JT, O’Brien T, Wells JA (2004) Discovery of an allosteric site in the caspases. Proc Natl Acad Sci U S A 101:12461–12466
Scheer JM, Romanowski MJ, Wells JA (2006) A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A 103:7595–7600
Velazquez-Delgado EM, Hardy JA (2012) Zinc-mediated allosteric inhibition of caspase-6. J Biol Chem 287:36000–36011
Denault JB, Eckelman BP, Shin H, Pop C, Salvesen GS (2007) Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem J 405:11–19
Boucher D, Blais V, Denault JB (2012) Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci U S A 109(15):5669–5674
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Boucher, D., Duclos, C., Denault, JB. (2014). General In Vitro Caspase Assay Procedures. In: V. Bozhkov, P., Salvesen, G. (eds) Caspases,Paracaspases, and Metacaspases. Methods in Molecular Biology, vol 1133. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0357-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0357-3_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0356-6
Online ISBN: 978-1-4939-0357-3
eBook Packages: Springer Protocols